Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Sarepta Therapeutics, Inc.

Clinical trials sponsored by Sarepta Therapeutics, Inc., explained in plain language.

Sarepta Therapeutics, Inc. SRPT NASDAQ

A biopharmaceutical company focused on RNA-targeted therapies for rare diseases.

Trade on eToro (ad)

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Trials to join now! 4 Not yet recruiting 1 Not yet finished but already full! 8 Completed 1 Terminated 5

New drugs aim to keep boys with duchenne walking longer

Disease control Completed

This study tested two drugs, casimersen and golodirsen, in 228 boys with Duchenne muscular dystrophy who have specific genetic mutations. The goal was to see if these drugs could slow muscle decline, measured by how fast they could climb four steps. Participants received either t…

Phase: PHASE3 • Sponsor: Sarepta Therapeutics, Inc. • Aim: Disease control

Last updated Jun 27, 2026 07:57 UTC